Enliven Therapeutics (ELVN) Tax Provisions (2024)
Enliven Therapeutics (ELVN) reported Tax Provisions of $232000.0 for Q2 2024.
Enliven Therapeutics (ELVN) Tax Provisions (2024) Analysis & Trends
Enliven Therapeutics (ELVN) has 1 years of Tax Provisions data on file, last reported at $232000.0 in Q2 2024.
- For the quarter ending Q2 2024, Tax Provisions changed N/A year-over-year to $232000.0; the trailing twelve-month figure through Jun 2025 stood at $232000.0 (changed N/A YoY), and the FY2024 full-year result was $232000.0, changed N/A from the prior year.
- Tax Provisions steadied at $232000.0 in Q2 2024.
- In the past five years, Tax Provisions ranged from a high of $232000.0 in Q2 2024 to a low of $232000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Enliven Therapeutics | 3.22 Bn | 3.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 232,000.00 |